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Abstract: Earlier studies suggested that the combination of alcohol use and immunodeficiency 
virus infection resulted in more severe neurologic disease than either condition individually. 
These deleterious interactions could be due to increased immune cell and virus trafficking or may 
result from interactions between ethanol and human immunodeficiency virus (HIV)-associated 
toxicity within the brain. To determine the extent to which increased trafficking played a role, 
we examined the effect of ethanol on the migration of different peripheral blood mononuclear 
cell (PBMCs) subsets across a brain endothelial cell monolayer. We utilized combinations of 
feline brain endothelial cells with astrocytes, and/or microglia with either acute exposure to 
0.08 g/dL ethanol, a combination of ethanol and feline immunodeficiency virus (FIV), or FIV 
alone. Adherence of PBMCs to endothelium was increased in all combinations of cells with the 
addition of ethanol. Despite increased PBMC adhesion with ethanol treatment, transmigration of 
B cells, monocytes, CD4 T cells and CD8 T cells was not increased and was actually decreased 
in the presence of astrocytes. Expression of three common adhesion molecules, intercellular 
adhesion molecule-1 (ICAM1), ICAM2, and vascular cell adhesion molecule, was unchanged 
or slightly decreased by ethanol. This indicated that although adherence is increased by ethanol 
it is not due to an increased expression of adhesion molecules. RANTES, MIP1α, MIP1β, and 
MCP-1 mRNA expression was also studied in brain endothelial cells, astrocytes and microglia 
by reverse transcriptase-polymerase chain reaction. Ethanol treatment of astrocytes resulted in 
modest changes of message while FIV caused 7–92-fold increases. The combination of ethanol 
and FIV reversed the large increase in RANTES and MIP1α message in astrocytes but increased 
MIP1β and MCP to 20–38-fold over control cells. Thus, modest concentrations of alcohol do 
not directly influence immune cell trafficking at the endothelium but may exert more complex 
effects on chemokine expression from astrocytes when combined with FIV .
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Introduction
The incidence of human immunodeficiency virus (HIV) and HIV-associated neurologic 
disease was reported at higher rates in alcohol abusers by some authors.1–5 However, it 
has been unclear whether or not the increase in central nervous system (CNS) infection 
and pathogenesis seen with alcohol consumption is due to a greater prevalence of high 
risk behaviors, more efficient penetration of human immunodeficiency virus (HIV) 
into the brain or synergistic pathological interactions. Experimental studies that were 
designed to explore the interactions of alcohol with HIV infection and pathogenesis 
have provided mixed results. Studies with simian immunodeficiency virus (SIV) 
showed that alcohol-exposed macaques had higher levels of cerebrospinal fluid (CSF) 
virus, plasma viremia, and more severe alterations in peripheral blood mononuclear HIV/AIDS - Research and Palliative Care 2010:2 
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cells (PBMC) subset numbers.6,7 An increased infection 
of PBMCs is seen after treatment with ethanol suggesting 
that these cells may be capable of delivering a greater viral 
load to target tissues.8 In addition, the effects of ethanol on 
endothelium may modulate PBMC adhesion and trafficking.9 
Both increases and decreases in adhesion were reported in 
peripheral endothelium.9–11 Alterations at the endothelium 
of vessels as suggested by Sacanella and colleagues12 may 
allow increased trafficking of PBMCs. If this change is also 
occurring at the brain endothelium, it may allow preferential 
trafficking of infected cells or increased trafficking of all 
PBMCs with greater access to the brain parenchyma. Yet 
other reports, focusing more on epidemiological studies,13,14 
suggested that earlier epidemiological data was misinter-
preted and that an association between alcohol and increased 
HIV pathogenesis was not present.
The feline immunodeficiency virus (FIV) model allows 
assessment of the effects of ethanol in a complete in vitro 
blood–brain barrier system that includes all potential cell 
targets (endothelial cells, astrocytes, and microglia). Using 
this model, we sought to determine if ethanol influenced 
PBMC trafficking across brain endothelium under normal 
conditions and in the presence of FIV . Feline brain endothe-
lial cells were cultured in the upper chamber of in vitro cell 
culture inserts and combined with astrocytes and/or microglia 
in the lower chamber to mimic the normal brain environment. 
The effect of ethanol on adherence of PBMCs to the endo-
thelial cell monolayer and transmigration of B cells, CD4 
T cells, CD8 T cells, and monocytes was measured.
Methods and materials
Cells and culture system
The source of tissue for cell cultures, isolation methods 
for CNS cells and PBMCs, characterization of these cells, 
presence of endothelial cell tight junctions, source of FIV , 
in vitro cell culture system, seeding protocols, immunocy-
tochemistry of trafficked cells, and automated cell counting 
software used in these experiments were previously described 
in detail.15 Two independent experiments with two or three 
replicates were used to produce an number of five or six for 
each experiment.
Briefly, the brains of deceased feline fetuses were 
removed, washed, and processed for culture of brain endo-
thelial cells (BECs), astrocytes, and microglia. The purity 
of these primary cultures was determined using specific cell 
markers and ranged from 80% for BECs to 95% for 
astrocytes and microglia. BECs were subcultured a maximum 
of six passages and cells from each passage were frozen for 
later use. Astrocytes were subcultured once and microglia 
were not subcultured.
Endothelial cells were seeded at 5 × 105/insert onto a 
transwell insert membrane coated with collagen and fibro-
nectin and containing 3 µm pores. Each transwell insert was 
placed into a well of a 24-well plate which constituted the 
lower chamber. BECs were allowed to grow to confluence, 
which was generally 2–3 days. For experiments that would 
ultimately include treated astrocytes or microglia, the 
appropriate cell type(s) was seeded at 1 × 105 cells into the 
lower chamber. Newly seeded BEC inserts were placed into 
the wells to allow exposure of BECs to any secreted factors 
normally produced by the accessory cells. A parallel set 
of plates with astrocytes and/or microglia were prepared 
identically. Brain endothelial cells were always grown in 
the upper chamber and were treated alone or in combina-
tion with astrocytes, and/or microglia in the lower chamber 
giving rise to four culture conditions: 1) endothelium (BECs), 
2) endothelium + astrocytes (BECs+A), 3) endothelium + 
microglia (BECs+MG) and 4) endothelium + astrocytes + 
microglia (BECs+A&MG). Cells received either no treat-
ment, ethanol, FIV, or ethanol and FIV treatment (see 
Table 1). On day 2 of co-culture, astrocytes or microglia 
(without endothelial cell monolayer inserts) were exposed 
to ethanol, ethanol and FIV- NCSU1, or FIV-NCSU1 in fresh 
medium for 24 hours. On day 3, the astrocytes or microglia 
were washed three times, and then the inserts with confluent 
BECs were transferred to the treated wells. To determine 
the direct effect of FIV and ethanol on the BECs, the same 
treatment conditions were applied to the confluent endothelial 
cell layer for 24 hours. The BECs were washed three times 
prior to addition of PBMCs. After the treatment of BECs, 
astrocytes, or microglia and the wash steps, 1 × 105 PBMCs 
were added to the upper chamber of each well for 24 hours. 
Cells in control configurations received fresh medium in lieu 
of treatment and wash steps.
Treatment with ethanol and FIV
Ethanol was added to medium at a concentration of 101.4 µL 
of 100% ethanol per 100 mL of medium to produce the 
equivalent of 80 mg/dL blood alcohol level (0.08%); the 
legal basis for drunk driving in the United States (http://www.
alcoholcontrols.com/lebaclibyst.html). In constructs where 
astrocytes or microglia were present, only the cells in the 
lower chamber received treatment (ie, not BECs). After wash-
ing treated cells three times, inserts with confluent untreated 
BECs were transferred to wells containing astrocytes and/or 
microglia. These studies of ethanol effects were run in parallel HIV/AIDS - Research and Palliative Care 2010:2 
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with other studies of PBMC trafficking.15 The FIV treatment 
was accomplished by adding 50 µL of a diluted NCSU1 strain 
of FIV to a final concentration of 5 × 104 TCID50/100 µL.16 
The normal control cultures and the FIV control cultures 
reported here represent a subset of the controls previously 
summarized.15
Peripheral blood mononuclear cells
For all experiments, anticoagulated blood was obtained 
from normal, specific pathogen-free cats. PBMCs were 
isolated on Percoll gradient and stimulated with 2 µg/mL 
concanavalin A overnight. These cells were then labeled 
with 5 µM Cell Tracker Orange® (Molecular Probes, 
Invitrogen, Carlsbad, CA, USA) per the manufacturer’s 
instructions. PBMCs were then added (1 × 105/well) to the 
upper chamber of the cell culture inserts. After 24 hours, the 
inserts were gently washed to remove nonadherent cells and 
mounted onto slides with the endothelial cell layer facing 
up (simulating the vascular lumen). Fluorescent PBMCs 
adhered to the surface of the BEC monolayer were counted 
in five fields (field = 0.2515 mm2) for each membrane using 
Metamorph® imaging software (Universal Imaging Corp. 
Westchester, PA, USA). Fluorescent objects were counted 
after filtering by size to only measure objects in the size 
range of white blood cells. Counts were averaged within 
each insert to provide a single value for each insert. The 
various configurations and number of replicates analyzed 
are summarized in Table 1.
The medium from the lower chambers of configura-
tions including transmigrated PBMCs was collected, evenly 
divided and cytospun onto two slides. The cells were then 
stained for CD3, CD4, CD8, B cell, or monocyte markers 
and manually counted as described previously.15 Techniques 
for double immunocytochemistry reduced the number of 
cytospins needed to count all PBMC subsets studied with 
each configuration and increased sample number.
Western blot analysis
Brain endothelial cells were grown to confluence in Iscove’s 
medium (Mediatech, Manassas, VA, USA) containing 10% 
fetal bovine serum (FBS; Mediatech, Manassas, VA, USA), 
20 µg/mL endothelial cell growth supplement (Collaborative 
Research, Bedford MA), 6 U/mL heparin (Sigma, St. Louis, 
MO, USA), 25 µg/mL gentamicin (Mediatech, Manassas, 
VA, USA), and 0.025 µg/mL amphotericin B (Mediatech, 
Manassas, VA, USA). Fresh medium was combined 1:1 
(v/v) with filtered conditioned medium from earlier BEC 
cultures. Fresh medium containing ethanol at 101.4 µL of 
Table 1 Configuration (ie, combinations) of cells and treatment regimens
BECs Astrocytes Microglia Astrocytes 
and microglia
Replicates (n)
no treatment X- 5
X- X- 5
X- X- 5
X- X- 5
ethanol treatment X+ 6
X- X+ 6
X- X+ 6
X- X+ 6
ethanol and FIV treatment X+ 6
X- X+ 6
X- X+ 6
X- X+ 6
FIV treatment X+ 5
X- X+ 5
X- X+ 5
  X-     X+ 5
Notes: X, cell type present in culture configuration; -, cell type present but did not receive ethanol and/or FIV treatment; +, cell type cocultured with ethanol and/or FIV 
treatment.
Abbreviations: FIV, feline immunodeficiency virus; BEC, brain endothelial cells.HIV/AIDS - Research and Palliative Care 2010:2 10
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100% ethanol/100 mL of medium (80 mg/100 dL), FIV at 
MOI of 0.5, or ethanol (same dose) plus FIV (same dose) 
were added to these cultures for 24 hours. Control cultures 
received fresh medium with no added ethanol or FIV. 
Cells were sonicated in buffer (50 mM Tris-HCl, 150 mM 
NaCl, 1 mM EDTA, pH 8.0) with 1% fresh stock cocktail 
of protease inhibitors (final concentrations: pepstatin A 
50 µg/mL, chymostatin 50 µg/mL, leupeptin 50 µg/mL, 
and aprotinin 100 µg/mL). Protein concentrations were 
determined by Bradford assay. Samples and controls were 
boiled for two minutes prior to loading. Positive control, 
negative control, and sample wells were loaded with 45 µg of 
protein in a denaturing SDS buffer. Samples were subjected 
to electrophoresis in a 7.5% polyacrylamide gel, and then 
transferred to polyvinylidene difluoride membrane overnight 
at 4 °C and 40 V. The membrane was blocked in 5% skim 
milk buffer overnight, incubated with primary antibody 
for intercellular adhesion molecule-1 (ICAM1), ICAM2, 
or vascular cell adhesion molecule (VCAM) (Table 2) for 
one hour at room temperature, then incubated with horse-
radish peroxidase (HRP)-conjugated secondary antibody 
for one hour at room temperature. Peroxidase activity was 
detected by chemiluminescence (Pierce Biotechnology, 
Rockford IL, USA). Bands were imaged using a bioimaging 
system and Labworks® software (UVP, Upland, CA, USA). 
The membranes were then stripped using a commercial 
product (Pierce Biotechnology) and reprobed for actin with 
an HRP-conjugated secondary antibody and chemilumi-
nescence as described above as a loading control. For the 
resulting figure, blot images were optimized by adjusting 
contrast to view bands and pertinent sample lanes were 
digitally placed adjacent to each other.
Real time reverse transcriptase-
polymerase chain reaction (RT-PCR)
Enriched feline endothelial cells, astrocytes, or microglia were 
grown in tissue culture flasks. Media containing ethanol, etha-
nol with FIV , FIV , and no treatment was applied for 24 hours to 
three independent studies. Ethanol was added to medium at a 
final concentration of 80 mg%. FIV was applied at an MOI of 
0.5. At the end of treatment, cells were collected and archived 
in RNAprotect Cell Reagent (Qiagen, Valencia, CA, USA). 
After thawing, cells were processed for RNA per manufac-
turer’s instructions (RNeasy Plus Mini Kit; Qiagen). cDNA 
was synthesized with integrated removal of genomic DNA 
contamination using 85 ng of RNA per reaction (QuantiTect 
Reverse Transcription Kit; Qiagen). RT-PCR quantification of 
cDNA was performed on the Icycler IQ (BioRad, Hercules, 
CA, USA) in specified reaction mixtures including primers 
(Table 3) for feline RANTES, MIP1α, MIP1β, MCP-1, and 
housekeeping G3PDH genes (QuantiTect SYBR Green PCR 
Kit; Qiagen). Negative controls included individual reactions 
containing each primer without the addition of cDNA; posi-
tive controls included reactions containing each primer with 
the addition of cDNA derived from feline PBMCs. Duplicate 
wells for each reaction step were performed and results were 
averaged. Fold increases and decreases were calculated 
using the method of Winer and colleagues.17
Statistical analysis
The absolute numbers of adherent and transmigrating 
PBMC subsets was variable from run to run resulting in a 
nonnormal distribution. Initially a Kruskal–Wallis analysis 
(P  0.05) of each cell configuration (eg, BECs configura-
tion with four treatment options) and of each treatment group 
(eg, untreated, ethanol-treated, ethanol- and FIV-treated, 
and FIV-treated BECs) was used. This was followed by 
Mann–Whitney analysis of data pairs (P  0.05) to further 
evaluate changes in adherence of PBMCs and transmigration 
within each PBMC subset (eg, CD4 t cell transmigration 
Table 3 Primer sequences for selected feline cytokines and 
housekeeping genes
Fe RAnTeS A: 5′-gCC/TCC/gCA/TCC/CCA/TAT/gCC 179 bp
B: 5′-CCC/ATT/TCT/TCT/gTg/ggT/Tgg
Fe MIP1α A: 5′-CTC/gCC/ATC/CTC/CTC/TgC/ACC 258 bp
B: 5′-ggC/ACT/CAg/CTC/CAA/gTC/Ag
Fe MIP1β A: 5′-CTC/CTT/gTg/CTA/gTg/gCT/gCC 200 bp
B: 5′-gTC/ACT/ggg/gTT/AgC/ACA/gAC
Fe MCP1 A: 5′-CTg/TgC/CTg/CTg/CTC/ATA/gCA/gC 189 bp
B: 5′-ggT/CTT/gAA/gAT/CAC/AgC/TTC
g3PDH A: 5′-CCT/TCA/TTg/ACC/TCA/ACT/ACA/T 400 bp
B: 5′-CCA/AAg/TTg/TCA/Tgg/ATg/ACC  
Abbreviations: RAnTeS, regulated upon activation, normal   T expressed and pre-
sumably secreted; MIP, macrophage inflammatory protein; MCP, macrophage chemoat-
tractant protein; g3PDH, glyceraldehyde 3-phosphate dehydrogenase.
Table 2 Western blot reagents
Primary 
Ab*/1:100
Secondary 
Ab*/1:10,000
Substrate** 
ICAM 1 Bovine anti-goat-HRP Chemiluminescence
ICAM 2 goat anti-rabbit-HRP Chemiluminescence
VCAM Bovine anti-goat-HRP Chemiluminescence
Actin Bovine anti-goat-HRP Chemiluminescence
Notes: *Santa Cruz Biotechnology, Santa Cruz, CA, USA; **Pierce Biotechnology 
kit, Rockford, IL, USA.
Abbreviations: HRP, horseradish peroxidase;  ICAM, intercellular adhesion molecule; 
VCAM, vascular cell adhesion molecule.HIV/AIDS - Research and Palliative Care 2010:2 11
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associated with untreated BECs vs ethanol-treated BECs or 
CD8 T cell transmigration associated with ethanol-treated 
BECs+A and ethanol-treated BECS+MG) (GraphPad Prism® 
software; GraphPad, La Jolla, CA, USA).
For RT-PCR, untreated cells were indexed to a value 
of 117 and relative increases and decreases were calculated 
for each experimental condition. Scores  1.96 standard 
error units from the controls were considered significant 
(P  0.05). Treated groups were analyzed with each other 
using Kruskal–Wallis analysis (P  0.05) and Mann–Whitney 
analysis of data pairs (P  0.05).
Results
effect of ethanol on PBMC adherence
The adherence of PBMCs was significantly increased after 
treatment of endothelial cells, astrocytes, or microglia with 
ethanol or with ethanol and FIV in all combinations of cells 
(Figure 1) compared to untreated cells and FIV treatment. 
FIV treatment resulted in a small but significant increase in 
adherence to the endothelium in the presence of astrocytes 
(Figure 1), which was reversed with the addition of microglia. 
The effect of ethanol was not influenced by the presence of 
astrocytes or microglia (light gray bars).
effect of ethanol on PBMC transmigration
Although the initial results supported increased adherence 
under ethanol treatment, transmigration of PBMCs did not 
follow the same trend. Endothelial cells with astrocytes had 
a relatively high level of trafficking across all PBMC subsets 
under normal conditions. Ethanol treatment decreased PBMC 
transmigration in this treatment group across all PBMC 
subsets. Endothelial cells with astrocytes also had a relatively 
high PBMC transmigration with FIV treatment, which was 
reversed by concurrent ethanol treatment. In Figures 2A–D, 
each cell subset was analyzed and the effect of treatments 
was assessed for each configuration.
For CD4 T cells (Figure 2A), there were no significant 
differences in transmigration within a particular configura-
tion of CNS cells due to wide biologic variation. Only the 
ethanol and FIV treatment group in the configuration with 
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Figure 1 Peripheral blood mononuclear cells (PBMC) adherence after no treatment (unTx), ethanol (EtOH Tx) treatment, EtOH and feline immunodeficiency virus (FIV) 
treatment (EtOH&FIV Tx) or FIV treatment (FIV Tx) of endothelial cells, astrocytes, and/or microglia. Astrocytes and/or microglia in the lower chamber of an in vitro cell 
culture insert system were treated or sham treated for 24 hours, and washed. Then inserts with confluent brain endothelial cells (BECs) were added to the well and cocultured 
with PBMCs for 24 hours. In the absence of astrocytes and microglia, BeCs received the treatment or control medium instead, and then were cocultured with PBMCs. error 
bars reflect standard error of the mean. Ethanol treatment showed dramatic, significant increases in mean adherence compared to untreated cells with all configurations of 
cells as did ethanol and FIV treatment (*P  0.05). The ethanol or ethanol and FIV treatment was significantly increased over FIV treatment within most configurations of 
cells (†P  0.05). For the treatment group receiving ethanol and FIV (dark gray bar) among the different configurations, those including microglia were significantly decreased 
relative to configurations without microglia (§P  0.05).   Additionally, in this treatment group, the configuration with BECs, astrocytes and microglia was significantly increased 
over the configuration with BECs and microglia (§§P  0.05).
Abbreviations: +A, astrocytes; +Mg, microglia.HIV/AIDS - Research and Palliative Care 2010:2 12
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endothelial cells, astrocytes and microglia, was significantly 
increased over other configurations of cells.
CD8 T cell transmigration (Figure 2B), was increased 
within the BECs+A configuration. The FIV-treated cells 
were significantly increased over untreated, ethanol-treated, 
and ethanol- and FIV-treated BECs+A. No effect of ethanol 
was seen. In addition the BECs+A configuration with FIV 
treatment was significantly increased over all other configura-
tions receiving FIV treatment.
Monocyte transmigration (Figure 2C), was significantly 
decreased in the presence of ethanol within the configura-
tion of BECs+A compared to FIV treatment. FIV treatment 
significantly increased transmigration of these cells between 
BECs and BECs+A configurations.
B cell transmigration (Figure 2D) was increased with 
BECs+A relative to BECs alone for both untreated and 
FIV-treated cultures. Ethanol suppressed transmigration of 
both the untreated cells and the FIV-treated cells.
The effect of ethanol on PBMC trafficking was sup-
ported by a failure to see increases in three common 
adhesion molecules. Western blot analysis of intercellular 
adhesion molecule-1 (ICAM1), ICAM2, and vascular 
cell adhesion molecule (VCAM) expression (Figure 3) 
showed that ethanol had no significant effect on adhesion 
molecule expression in the endothelial cells.
Changes in mRNA for four chemokines (RANTES, 
(regulated upon activation, normal  T expressed and presum-
ably secreted), MIP1α, MIP1β, and MCP-1) associated with 
Figure 2 Peripheral blood mononuclear cells (PBMC) subset transmigration after treatment of brain endothelial cells (BECs), astrocytes (+A), and/or microglia (+MG) 
with ethanol (EtOH Tx), ethanol and FIV (EtOH&FIV Tx), FIV (FIV Tx) or no treatment (unTx). CD4 T cells, CD8 T cells, monocytes, B cells were collected from the lower 
chamber of the cell culture insert system and cytospins were produced. Immunocytochemistry was used to identify each subset and slides were manually counted. error 
bars reflect standard error of the mean. For all subsets of PBMCs, the inclusion of ethanol in the treatment in the BECs+A configuration yielded a decrease in transmigration. 
A) For CD4 T cells: In the EtOH and FIV treatment group, the configuration of BECs+A&MG was significantly increased over all other cell configurations receiving the same 
treatment (*P  0.001). B) For CD8 T cells: In the FIV treatment group, the BECs+A significantly increased transmigration compared to other treatment groups with the 
same cell configuration (**P  0.05). In addition, the FIV-treated cells of this (BECs+A) configuration had significantly increased CD8+ T cell transmigration compared to all 
other cell configurations with FIV treatment (*P  0.001). C) For monocyte cells: In the BECs+A configuration, ethanol and ethanol+FIV treatments significantly decreased 
transmigration compared to FIV treatment (§§P  0.01). The FIV-treated cells of this (BECs+A) configuration had significantly increased monocyte transmigration compared 
to the configuration of BECs alone (§ P  0.01). D) For B cells: In the BECs+A configuration, ethanol treatment significantly decreased transmigration compared to untreated 
cells and FIV treatment (§§P  0.001). The untreated cells of this (BECs+A) configuration had significantly increased B cell transmigration compared to the untreated BECs 
configuration, and to the untreated BECs+MG configuration (***P  0.001).   The FIV-treated cells of this (BECs+A) configuration had significantly increased B cell transmigra-
tion compared to all other configurations of cells with FIV treatment (*P  0.01).
Abbreviation: FIV, feline immunodeficiency virus.
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chemotaxis of PBMCs were also studied. Astrocytes (Figure 4) 
treated with ethanol demonstrated significant changes in mes-
sage of all four chemokines compared to untreated cells. RAN-
TES and MIP1α were both increased slightly (3–4-fold) while 
MIP1β and MCP-1 were decreased 2–6-fold. These changes 
were small when contrasted to the effects of FIV where sub-
stantial increases were seen for each chemokine (RANTES, 
35-fold; MIP1α, 92-fold; MIP1β, 7-fold; MCP-1, 10-fold). 
Treatment with ethanol with FIV decreased RANTES and 
MIP1α and increased expression of MIP1beta and MCP-1 
to 20-fold and 38-fold above controls, respectively.
Microglia generally demonstrated small or negligible 
changes in RANTES, MIP1α, MIP1β, and MCP1 with any 
of the three treatments (Figure 5A) relative to untreated cells. 
MCP1 was slightly increased by FIV and RANTES, MIP-1α 
and MIP-1β decreased by ethanol.
Brain endothelial cells generally showed significant 
decreases in RANTES and MCP-1 messages and increases 
Figure 4 mRNA message levels of four chemokines in astrocytes. Cells were untreated (unTx), treated with ethanol (EtOH) to equal 0.08 mg/dl in human blood for 24 hours, 
treated with same concentrations of ethanol plus FIV (at MOI of 0.5) (EtOH&FIV), or treated with MOI of 0.5 of FIV respectively, for 24 hours. Fold changes were indexed 
to untreated cells (0 line). *P  0.05 of indicated bar compared to untreated cells. **P  0.05 for ethanol and FIV treatment compared to ethanol alone. †P  0.05 for 
FIV treatment compared to ethanol alone. ††P  0.05 for FIV treatment compared to ethanol and FIV treatment.
Abbreviations: RANTES, regulated upon activation, normal   T expressed and presumably secreted; MIP, macrophage inflammatory protein; MCP, macrophage chemoattractant 
protein; FIV, feline immunodeficiency virus; MOI, multiplicity of infection.
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Figure 5   A) mRNA message levels of four chemokines in microglia and B) brain endothelial cells. Cells were untreated (unTx), treated with ethanol (EtOH) to equal 0.08 mg/dL 
in human blood for 24 hours, treated with same concentrations of ethanol plus FIV (at MOI of 0.5) (EtOH&FIV), or treated with MOI of 0.5 of FIV respectively, for 24 hours. 
Fold changes17 were indexed to untreated cells (0 line). *P  0.05 of indicated bar compared to untreated cells. **P  0.05 for ethanol and FIV treatment compared to ethanol 
alone. †P  0.05 for FIV treatment compared to ethanol alone. ††P  0.05 for FIV treatment compared to ethanol and FIV treatment.
Abbreviations: RANTES, regulated upon activation, normal   T expressed and presumably secreted; MIP, macrophage inflammatory protein; MCP, macrophage chemoattractant 
protein; FIV, feline immunodeficiency virus; MOI, multiplicity of infection.
in MIP1α and β message (Figure 5B) under all treatments 
compared to untreated cells. The magnitude of these changes 
was generally greater than that seen for microglia but much 
less than that seen for astrocytes.
Discussion
It has been hypothesized that abuse of drugs, including 
alcohol, increases the risk of CNS pathogenesis through a 
variety of mechanisms. Some investigators have suggested 
that alcohol use may lead to loss of inhibitions with increased 
high risk sex behaviors resulting in increased probability 
of HIV exposure(s).18–20 Other studies have indicated that 
alcohol abuse may independently increase the percentage 
of HIV+ patients with neurologic manifestations.1,5 These 
latter observations have raised questions about the specific 
impact of ethanol on HIV infection and neuropathogenesis. HIV/AIDS - Research and Palliative Care 2010:2 16
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Various hypotheses have suggested that ethanol abuse could 
increase viral titers, result in an increase in immune cell 
trafficking or synergize with pathogenic mechanisms in the 
CNS. The possibility that ethanol might influence immune 
cell trafficking is particularly interesting since it may not 
only influence the penetration of infected cells but alter the 
CNS immune response to HIV . In addition, since it readily 
penetrates the blood–brain barrier, ethanol effects could be 
exerted centrally. Evidence in support of increased immune 
cell trafficking has derived, in part, from studies showing 
alcohol-related endothelial cell damage, increased permeabil-
ity and increased expression of chemokine receptors which 
serve as co-receptors for HIV .21 Less work has been done to 
document changes in the transmigration of various immune 
cells across the endothelium during exposure to moderate 
concentrations of ethanol.
Since many cell types may be influenced by ethanol, 
we used an in vitro model that allowed assessment of the 
potential contribution of endothelial cells, astrocytes, or 
microglia. The contribution of each cell type to immune cell 
trafficking was determined by exposure to modest concentra-
tions of ethanol to reflect a moderate level of abuse. In this 
investigation, PBMC adherence was significantly increased 
after treatment with ethanol for all combinations of cells but 
the presence/absence of astrocytes and microglia had no 
effect. The ethanol concentration was at modest physiologic 
levels,22,23 80 mg%, reflecting moderate chronic abuse. The 
results do not address possible changes under conditions of 
high acute abuse where blood concentrations may rise to 
500 mg%. FIV treatment alone did not significantly alter 
PBMC adherence as reported previously.15 The presence of 
microglia suppressed the ethanol-induced adherence of the 
PBMCs although levels were still above basal adherence.
As adherence is an early step in the trafficking mechanisms, 
this finding suggested that ethanol might enhance PBMC 
trafficking into the CNS. However, this possibility was not 
supported by the transmigration experiments. Such findings 
provide additional support that the control mechanisms 
for the different steps of trafficking are not directly linked, 
ie, the act of adherence does not automatically cause cellular 
transmigration. Treatment with either ethanol or ethanol in 
the presence of FIV generally resulted in markedly decreased 
numbers of transmigrated cells. This was in agreement with 
Saeed and colleagues10 where leukocyte transmigration was 
decreased in peripheral tissues after acute ethanol exposure. 
The lack of any synergism between alcohol and FIV further 
indicated that circulating virus does interact with ethanol to 
influence trafficking.
Penetration of PBMC subsets across the blood–brain 
barrier was similar to previous reports15 for untreated cells 
and FIV-treated cells indicating active regulation of immune 
cell transmigration in this paradigm. A positive effect of 
astrocytes on cell trafficking at the blood–brain barrier has 
been reported previously.15 While the mechanism of this 
is still not understood, it is clear that astrocytes can exert 
significant control over immune cell trafficking. In contrast, 
microglia are frequently seen to suppress the astrocyte 
effect.15,24 Thus, drugs of abuse have the potential to influence 
immune cell trafficking through a variety of mechanisms 
involving several different cell types. Exposure to ethanol 
eliminated these interactions suggesting an early block of 
transmigration.
The lack of transmigration with ethanol treatment was 
corroborated by a failure to see increases in supportive 
mechanisms. Conditions known to support immune cell 
trafficking such as exposure to cytokines will upregulate 
adhesion molecules, such as VCAM, ICAM1, and E-selectin 
in endothelial cells.25–28 However, none of the three common 
adhesion molecules that we examined showed increased 
protein expression after ethanol or ethanol plus FIV . This 
finding generally agreed with the observations of Saeed and 
colleagues10 in which ethanol alone decreased total VCAM 
and E-selectin expression on peripheral endothelial cells. 
It was also shown that FIV alone did not increase expression 
of total protein or message of ICAM1, ICAM2, or VCAM 
in feline BECs.24 On the contrary ICAM2, which was most 
abundantly expressed, was decreased about 50% following 
FIV treatment of the endothelial cells as had been reported 
previously.24 These observations suggested that the PBMC 
adherence seen in coculture was either the result of some other 
adhesion molecule(s) or perhaps a nonspecific interaction.
Changes in chemokine message supported previous 
findings highlighting the important role of astrocytes and 
microglia in the transmigration of  PBMCs. Again the interpre-
tation is limited by a lack of feline-specific reagents suitable 
for the analysis of chemokine protein. The highest levels of 
transmigration for CD4 T cells, CD8 T cells, monocytes and 
B cells were associated with the presence of astrocytes. FIV 
treatment further increased the transmigration of monocytes. 
Astrocytes expressed the highest level of chemokine mRNA 
and showed the greatest increases following exposure to FIV , 
which may explain their prominent effects on immune cell 
transmigration. Ethanol alone showed low increases or even 
decreases in cytokine message in the astrocytes. However, 
the combination of ethanol and FIV resulted in a significant 
increase in MIP1 beta and MCP-1 mRNA. This synergism HIV/AIDS - Research and Palliative Care 2010:2 1
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by ethanol failed to translate to an increase in transmigration. 
Together these observations suggest that the general suppres-
sion of transmigration by ethanol was most likely due to a 
failure at early stages of transmigration.
Thus, the possibility that moderate alcohol abuse might 
result in more effective PBMC transmigration in infected 
or uninfected individuals was not supported by this study. 
Instead alcohol suppressed transmigration of all PBMC 
subsets in the vast majority of configurations. This suppres-
sion of trafficking could be interpreted in different ways. 
On the one hand, it could restrict entry of infected cells into 
the CNS and slow early disease progression. On the other 
hand, inefficient trafficking of immune cells may eliminate 
important mechanisms needed for control of viral replica-
tion and clearance of virus from the CNS which appears to 
be an early protective response.29 A further consideration 
is that the alcohol level utilized was at the legal limit for 
intoxication and it remains possible that higher levels and 
chronic administration for greater than 24 hours may dif-
ferentially affect CNS trafficking. For example, opposite 
effects of ethanol have been seen with in vitro toxicity stud-
ies with low levels protecting against gp120 toxicity and 
high doses synergizing with gp120 toxicity. Our findings 
do not address effects in peripheral systems nor do they 
exclude alterations in the trafficking of cells and virus at 
the choroid plexus.30,31
Overall, attempts to understand the role of ethanol abuse 
in HIV neuropathogenesis need to factor in the potential 
effects of decreased immune cell trafficking as well as 
possible changes in chemokine signaling by astrocytes. More 
work is clearly needed to fully appreciate the various interac-
tions of ethanol in neuroinflammatory and neuroprotective 
processes.
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